ReviewJournal of personalized medicine2021

The SGLT-2 Inhibitors in Personalized Therapy of Diabetes Mellitus Patients.

Mariana Cornelia Tilinca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.